It is tempting to speculate that the lack of radiosensitisation in the noncancer MCF10A cells at doses <10 Gy suggests that the combination of ATR inhibition with moderately hypofractionated radiation therapy would achieve tumour-selective radiosensitisation and be well tolerated. This evidence concerns the gene ATR and neoplasm.